Surgical Oncology at Saint Louis University
General Surgery
Dr. Eddy C. Hsueh, MD
|
|
Give Review
Eddy C. Hsueh practices General Surgery. He attended University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10 in research and 19 in primary care medicine He received awards:"Fellow (FACS)" and "Top MD". Eddy C. Hsueh, MD is also published. He has 49 publications published. The lastest publication: "Enhancement of complement-dependent cytotoxicity by polyvalent melanoma cell vaccine (CancerVax): correlation with survival.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- TLR8 signaling enhances tumor immunity by preventing tumor-induced T-Cell senescence.
- Increased Th17 Cells in the Tumor Microenvironment Is Mediated by IL-23 via Tumor-Secreted ProstaGlandin E2.
- Tumor-Derived ?? Regulatory T Cells Suppress Innate and Adaptive Immunity through the Induction of Immunosenescence.
- Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast Cancer.
- Current surgical management of pancreatic Cancer.
- Rationale for complete metastasectomy in patients with stage IV metastatic Melanoma.
- Anti-miR-203 Upregulates SOCS3 Expression in Breast Cancer Cells and Enhances Cisplatin Chemosensitivity.
- Tumor microenvironments direct the recruitment and expansion of human Th17 Cells.
- Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-Cell melanoma vaccine.
- Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic Cancer (PC), and normal pancreas.
- Fine needle aspiration biopsy of splenic hamartoma with bizarre stromal Cells: a case report.
- Peripheral blood CD4+ T-Cell response before postoperative active immunotherapy correlates with clinical outcome in metastatic melanoma.
- Allelic imbalance of 12q22-23 associated with APAF-1 locus correlates with poor disease outcome in cutaneous Melanoma.
- Prolonged survival after complete resection of metastases from intraocular Melanoma.
- Melanoma-inhibiting activity assay predicts survival in patients receiving a therapeutic Cancer vaccine after complete resection of American Joint Committee on Cancer ...
- Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent Cancer vaccine.
- Is sentinel lymph node mapping indicated for isolated local and in-transit recurrent Melanoma?
- Lymphatic mapping and sentinel lymphadenectomy for early-stage Melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving...
- Serum total ganglioside level correlates with clinical course in melanoma patients after immunotherapy with therapeutic Cancer vaccine.
- Androgen blockade enhances response to Melanoma vaccine.
- Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic Cancer vaccine.
- Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of Melanoma metastatic to regional ...
- Active immunotherapy by reinduction with a polyvalent allogeneic Cell vaccine correlates with improved survival in recurrent metastatic melanoma.
- Hypoglycemia with a Large retroperitoneal mass - Case report.
- Neoadjuvant treatment of Melanoma: case reports and review.
- Metaplastic breast Cancer: histologic characteristics, prognostic factors and systemic treatment strategies.
- Radiofrequency ablation: a minimally invasive technique with multiple applications.
- CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma Cells.
- Prognostic implications of thick (>or=4-mm) Melanoma in the era of intraoperative lymphatic mapping and sentinel lymphadenectomy.
- Humoral immune response to a therapeutic polyvalent Cancer vaccine after complete resection of thick primary melanoma and sentinel lymphadenectomy.
- Tumour Cell-based vaccines for the treatment of melanoma.
- Lymphoscintigraphy and lymphatic mapping for identification of sentinel lymph nodes.
- Serum TA90 antigen-antibody complex as a surrogate marker for the efficacy of a polyvalent allogeneic whole-cell vaccine (CancerVax) in melanoma.
- CytoreDuctive surgery and adjuvant immunotherapy: a new management paradigm for metastatic melanoma.
- Tumor-associated antigen TA90 immune complex assay predicts recurrence and survival after surgical treatment of stage I-III Melanoma.
- Application of an [(18)F]fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy.
- Intraoperative lymphatic mapping and sentinel lymph node dissection in breast Cancer.
- Does endogenous immune response determine the outcome of surgical therapy for metastatic Melanoma?
- Metastasectomy for recurrent stage IV Melanoma.
- Active specific immunotherapy with polyvalent melanoma Cell vaccine for patients with in-transit melanoma metastases.
- Survival of patients with Melanoma of the lower extremity decreases with distance from the trunk.
- Enhancement of complement-dependent cytotoxicity by polyvalent melanoma cell vaccine (CancerVax): correlation with survival.
- Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma Cell vaccine.
- Positron emission tomography plus serum TA90 immune complex assay for detection of occult metastatic Melanoma.
- TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV Melanoma.
- Posttranslational modification of ras proteins: detection of a modification prior to fatty acid acylation and cloning of a gene responsible for the modification.
- The rat Liver asialoglycoprotein receptor polypeptide must be inserted into a microsome to achieve its active conformation.
- Human tumor-infiltrating Th17 Cells have the capacity to differentiate into IFN-γ+ and FOXP3+ T Cells with potent suppressive function.
Schools
University Of ChicagoThe Pritzker School Of Medicine
SUNY Hlth Sci Ctr
University Hospital Of Brooklyn Downstate
John Wayne Canc Inst
University of Chicago
Procedures Preformed
- Abdominal Surgery
- Adjacent Tissue Transfer
- Appendectomy, Laparoscopic
- Colectomy
- View All
Conditions Treated
- Adrenal Gland Cancer
- Appendicitis
- Basal Cell Carcinoma
- Bile Duct Cancer
- View All
Doctors Specialties
- Complex General Surgical Oncology
- General Surgery
- Hepatopancreaticobiliary Surgery
- Laparoscopic Surgery
- Surgical Oncology
Accepted Insurances
Awards
- Fellow (FACS)
- Top MD
Education
-
SUNY Health Science Center at Brooklyn -
University of Chicago Pritzker School of Medicine
Drug Facts
| NPI NUMBER | 1003910225 | |
| NPPES Provider LastName | HSUEH | |
| NPPES Provider FirstName | EDDY | |
| NPPES Provider ZIPCode | 63110 | |
| NPPES Provider State | MO | |
| Specialty Description | General Surgery | |
| Total Claim Count | 388.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 125.0 | |
| Percent Opioid Claims | 32.22 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1003910225 |
| Last Name Of The Provider | HSUEH |
| First Name Of The Provider | EDDY |
| View All |
Similar Doctors
|
Dr. Robert N. Westerman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas J. Francel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kareem D. Husain, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Angela M. Ware, DO |
|
|
Dr. Kelly M. Collins, MD |
|
|
Dr. Fatema I. Almushawah, MD |